Pluristem Announces DMC Recommendation Following Interim Analysis of its Phase III CLI Study

NEXT STORY
Global Diagnostic Specialty Antibodies Market Report 2020-2025: Growing R&D Expenditure in Biotech and Pharma Companies
PREV STORY
Everest Medicines Announces First Patient Dosed in Phase 3 Registration Asian Study of TrodelvyTM (sacituzumab govitecan) for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Idorsia Japan confirms daridorexant dose response in Japanese patients with insomnia – preparation for a local registration program advancing

author_avatar
NASDAQ Market News

Resuscitation Devices Market Was Worth US$ 6.2 Billion in 2019 and is Expected to Reach US$ 10.3 Billion at a CAGR of 4.9%

author_avatar
NASDAQ Market News

ETFO members’ survey shows violence pervasive in schools

Toronto, ON, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Seventy per cent of members of ...

author_avatar
NASDAQ Market News